Global Liver Institute
News
GLOBAL LIVER INSTITUTE
Good Health is the Essence of Freedom
As we approach Independence Day this weekend during a COVID-19 pandemic that is resurgent in 37 of 50 of the United States we recognize that good health and good policy go hand in hand. Strong local, state, and federal leadership, public health policy, scientific research policy, and nimble…
COVID-19 AND Liver Patients: Workplace Edition
Throughout these past many months, we have all been working to stay safe, healthy, and up to date on all things COVID-19 related. The GLI team has been actively engaging with fellow advocacy groups, healthcare professionals, and liver patients to learn and understand COVID-19 and how it impacts our health and our daily lives. We have been staying connected…
Breaking News: Painting An Accurate Cost Picture Of NASH Treatment
This week Global Liver Institute (GLI) submitted comments on the Institute for Clinical and Economic Review (ICER) draft evidence report entitled “Obeticholic Acid for the Treatment of Nonalcoholic Steatohepatitis with Fibrosis.”…
Focus on Liver Cancer (HCC) Care
The effects of the novel coronavirus pandemic on liver patients’ ability to access non-COVID-19 related care have been broad, and pervasive. The guidance for initiation of treatment and management for patients with viral hepatitis, transplant, and cancer have been in flux during…
April 3, 2020 Recent Updates and Answers to Questions for Liver Patients during COVID-19
We recently recognized National Doctor’s Day in the US and joined people from around the world to applaud and celebrate all medical professionals working in the trenches and on the frontlines of care, fighting the coronavirus pandemic without rest or pause. Tens of thousands…
March 27, 2020 Recent Updates for Liver Patients during COVID-19
Either by the immunosuppressive nature of our conditions or as an effect of the medications we are taking, liver patients should be considered vulnerable and at high-risk for contracting a COVID-19 infection. Patients should stay home and should not Travel. The evidence continues…
Questions and Answers About COVID-19
The novel coronavirus pathogen known as “SARS-CoV-2” and the disease it causes, COVID-19 has infected enough people in enough countries to be declared by the World Health Organization (WHO), a global pandemic…
GLI Responds to AOPO’s Recent Misinformation Campaign
In response to AOPO’s recent misinformation campaign, GLI sent this letter to HHS in support of the Administration’s efforts to bring accountability to the organ procurement organizations’ performance. Our letter provides factual corrections to AOPO’s claims…
Excellence in Liver Care Spotlight: Veterans Health Administration
The HIV, Hepatitis, and Related Conditions Programs (HHRC) in the Veterans Health Administration (VA) is working to improve care for viral hepatitis and liver disease. The VA has seen many recent accomplishments in the treatment and cure of Veterans in VA care with hepatitis C and look to build on these successes for Veterans with hepatitis B and advanced liver disease (ALD)…
Support PBC Research: What to do after #RAREDISEASEDAY
Do you have PBC? Rare Disease Day, celebrated across social media and IRL on the last day of the shortest month of the year, is a growing global movement, shining a light on the thousands of conditions cumulatively affecting tens of millions of people.
April Health Policy Update
With Republicans in the White House and holding majorities in both houses of Congress it seemed that nothing could stand in the way of repealing and replacing the Affordable Care Act (ACA), also known as ObamaCare, however, after years of campaigning on this issue, no consensus bill, in fact, has been developed by either Congress or the new Administration. The first attempt to repeal and replace the (ACA) came…
A Fourth Pillar of Liver Cancer Care
Our March LiverMatters blog highlights how innovation is creating new options for treating liver cancer, in fact establishing an entirely new approach through interventional radiology. Please read this timely brief article by Lance Funderburk…